Description
Oxervate (cenegermin-bkbj) ophthalmic solution 0.002% is a recombinant human nerve growth factor (rhNGF) indicated for the treatment of neurotrophic keratitis, a rare degenerative disease of the cornea characterized by reduced or absent corneal sensitivity. Oxervate promotes corneal healing by supporting nerve regeneration and epithelial repair. This sterile, preservative-free eye drop is the first FDA-approved treatment targeting the underlying nerve damage in neurotrophic keratitis.
Fact Table |
Formula | C7650H11990N2030O2400S50 |
License | US FDA, EMA |
Bioavailability | Topical (ocular); systemic absorption is minimal |
Legal status | Rx-only |
Chemical Name | Cenegermin |
Elimination half-life | Not systemically measurable; rapidly degraded locally |
Dosage (Strength) | 0.002% (20 mcg/mL) ophthalmic solution |
Pregnancy | Consult a doctor; no adequate human data |
Brands | Oxervate |
Protein binding | Not applicable (topical application) |
PubChem CID | 16129693 |
MedlinePlus | a619064 |
ChEBI | N/A (not assigned) |
ATC code | S01XA21 |
DrugBank | DB13931 |
KEGG | D11124 |
Routes of administration | Ophthalmic (topical eye drops) |
Directions
Oxervate should be administered as one drop in the affected eye(s), six times daily at intervals of approximately two hours for eight consecutive weeks. Contact lenses should be removed before application and may be reinserted 15 minutes after administration. The treatment should be initiated and supervised by an ophthalmologist experienced in managing neurotrophic keratitis.
Ingredients
Active Ingredient: Cenegermin-bkbj (recombinant human nerve growth factor) 0.002% (20 mcg/mL) Inactive Ingredients: L-methionine, mannitol, polysorbate 20, sodium phosphate monobasic monohydrate, trehalose dihydrate, water for injection. The solution is pH-adjusted to 7.0.
Contraindications
Oxervate is contraindicated in patients with known hypersensitivity to cenegermin or any of the formulation components.
Cautions
Use with caution in patients with active ocular infections. Proper hygiene and aseptic technique must be followed during administration to avoid contamination. The dropper vial should not come into contact with the eye or surrounding surfaces. As the product is preservative-free, any unused portion must be discarded immediately after use. Avoid use in conjunction with other ophthalmic medications unless advised by a healthcare provider.
Side Effects
Common side effects may include:
- Ocular hyperemia (eye redness)
- Increased lacrimation (tearing)
- Corneal deposits Less commonly, patients may experience eyelid pain or visual disturbances. If severe reactions occur, treatment should be discontinued and a healthcare professional consulted.
IMPORTANT NOTE:
The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.
Product Code : 14197